TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/05/2025
Back to search
Official data from USPTO
CYTUNE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
08/10/2025
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
12/17/2020
Registration date
09/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2022
Last transaction
08/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Nantes, FR
Examiner
ZARICK, DIANA
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "CYTUNE" in black; to the left is an arrowhead shaped figure in oblong lines with the top in magenta and the bottom in orange.
Holders and representatives
Holders
Cytune Pharma S.A.S.
Representatives
Shane Rumbaugh Rumbaugh Law PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsmedical and veterinary preparations for the prevention and treatment of neoplasiatumorscancer and infectious diseases; anticancer preparations; antitumor drugs in the nature of tumor suppressing agents; vaccines; anticancer vaccines; pharmaceutical preparations for the treatment of neoplasiatumorscancer and infectious diseasespeptidesrecombinant proteinsantibodiesantibody derivativesantibody-drug conjugatesnucleotides and nucleotide analogs for medical and veterinary purposes; biological preparations for the treatment of neoplasiatumorscancer and infectious diseases for medical and veterinary purposes; cellular preparations for the treatment of neoplasiatumorscancer and infectious diseases for medical and veterinary purposes; radiopharmaceutical preparations for the treatment of neoplasiatumors and cancer for diagnosticmedical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and infectious diseases; diagnostic agentspreparations and test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectionneoplasiatumorscancer and infectious diseases for medical and veterinary purposes; drug delivery agents; adjuvants for medical use; dietetic substances adapted for medical use
Class 42
Scientific and technological servicesresearch and design in the field of biotechnological and pharmaceutical research and development; industrial analysis and research services in the field of biotechnological and pharmaceutical research and development; scientific research for medical and veterinary purposes; scientific research and development for medical and veterinary purposes in the area of cancerous diseasesautoimmune diseases and infectious diseases; pharmaceutical drug development services; conducting clinical trials for others; scientific preclinical and clinical research in the field of prevention and treatment of neoplasiatumorscancer and infectious diseases; scientific preclinical and clinical research in the fields of biologics and chemotherapy; analysis of toxicology and mode of action of biological and chemicals and combinations on animals; pharmaceutical and biological product researchdevelopmentsafety testingquality control testing services for others; scientific research and development for diagnostic purposes; computer-aided diagnostic testing services in the nature of computer diagnostic services; design and development of computer software and databases; design and development of computer software and databases for logisticssupply chain management and laboratory management
Class 44
Medical services; medical diagnostic services
Publications
History of USPTO decisions and trademark events.
42 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/16/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/16/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/16/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2022
PUBO
PUBLISHED FOR OPPOSITION
07/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/15/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2022
GNRT
NON-FINAL ACTION E-MAILED
02/07/2022
CNRT
NON-FINAL ACTION WRITTEN
02/07/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/31/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/11/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/27/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/27/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/27/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/27/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/18/2021
ALIE
ASSIGNED TO LIE
12/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/13/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/30/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/30/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/30/2021
DOCK
ASSIGNED TO EXAMINER
09/29/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/18/2021
GNRT
NON-FINAL ACTION E-MAILED
06/18/2021
CNRT
NON-FINAL ACTION WRITTEN
06/18/2021
DOCK
ASSIGNED TO EXAMINER
06/11/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/26/2021
NWAP
NEW APPLICATION ENTERED
12/21/2020
Continuous trademark protection
Get notified about every new filing that threatens CYTUNE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.